CNBC: Astra Zeneca says its coronavirus vaccine triggers immune response among adults
The University of Oxford and Astra Zeneca are collaborating on the development of a coronavirus vaccine. With recent evidence, their vaccine appears to be one of the frontrunners for a vaccine available by the end of the year. Recent studies showed that an immune response was developed in response to the vaccine in both older and younger populations. Scientists are particularly interested in the immune response in older populations, given their vulnerability to the disease. The vaccine also produced less adverse reactions in the elderly population, increasing hopes in the vaccine’s effectiveness. To read the full article, click here.